Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00292123

Enrollment

200

Registered

2006-02-15

Start date

1999-06-30

Completion date

2006-08-31

Last updated

2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine Abuse, Opioid Dependence

Brief summary

The primary goal of this study is to determine how contingency management can best be combined with standard or high doses of methadone to increase simultaneous abstinence from heroin and cocaine.

Detailed description

A study of people pmaintained on Methadone using contingency management

Interventions

DRUGMethadone

BEHAVIORALContingency Management

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Opioid dependence; cocaine use

Exclusion criteria

* Medical or psychiatric conditions that would contraindicate participation in a methadone maintenance study; inability to give informed consent; inability to attend clinic seven days a week

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026